The invention relates to a human immunoglobulin G composition characterized in that the human immunoglobulin G concentration is at least 230 g/l, which is of use in particular for subcutaneous administration.
申请公布号
WO2012017156(A1)
申请公布日期
2012.02.09
申请号
WO2011FR51712
申请日期
2011.07.18
申请人
LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES;HUILLE, SYLVAIN;COHEN-TANNOUDJI, LAETITIA;ARVIS, FLORENCE;PAILLARD, ALEXANDRA
发明人
HUILLE, SYLVAIN;COHEN-TANNOUDJI, LAETITIA;ARVIS, FLORENCE;PAILLARD, ALEXANDRA
